NORDIC BIOTECH ADVISORS ApS: Financial statements 2025
CVR: 26123925
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NORDIC BIOTECH ADVISORS ApS (CVR 26123925) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. That is an increase of 74.6% compared with the year before. Equity in the 2025 report amounted to DKK 4,622,219. The solvency ratio was 85.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,273,154
- Profit/Loss
- DKK 360,368
- Equity
- DKK 4,622,219
- Total Assets
- DKK 5,382,181
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.3M | 360K | 4.6M | 2 |
| 2024 | - | 1.9M | -573K | 4.3M | 2 |
| 2023 | - | 4.5M | 1.4M | 4.8M | 2 |
| 2022 | - | 3.8M | 943K | 3.4M | 2 |
| 2021 | - | 3.7M | 657K | 2.5M | 2 |
Official annual report
How creditworthy is NORDIC BIOTECH ADVISORS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
NORDIC BIOTECH ADVISORS ApS has published its annual report for 2024. Gross profit came to DKK 1,874,965, and the net result was DKK -572,578.
About NORDIC BIOTECH ADVISORS ApS
NORDIC BIOTECH ADVISORS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is registered under the industry Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. The company was previously named NEXGEN BIOTECH ApS and NORDIC BIOTECH ApS. The management consists of Florian Schønharting. The board consists of Florian Schønharting and Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. Equity in the 2025 report amounted to DKK 4,622,219.
